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The original version of this article contained an error in Fig.
5a where the colours of the labels representing the Hinge
and LBD of the AR were incorrect and did not match the
corresponding exons. The corrected version of this Figure
now appears in the article. The conclusions of this paper
were not affected. The authors apologise for this error and
any confusion caused.
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